Profusa (NVACW) Convertible Debt (2023 - 2026)
Profusa posted quarterly Convertible Debt of $2.5 million for Q1 2026, up 4.6% year-on-year from $2.4 million in Q1 2025, and up 8.7% on a QoQ basis from $2.3 million in Q4 2025.
Profusa (NVACW) has 4 years of Convertible Debt data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Convertible Debt rose 4.6% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 4.6% YoY), and the FY2025 full-year result was $2.3 million, up 4.55% from the prior year.
- Convertible Debt for Q1 2026 stood at $2.5 million, up from $2.3 million in the prior quarter.
- Across five years, Convertible Debt topped out at $2.5 million in Q2 2025 and bottomed at $310999.0 in Q2 2023.
- The 4-year median for Convertible Debt is $2.0 million (2024), against an average of $1.8 million.
- The widest annual swing landed in 2024, when Convertible Debt jumped 491.0%; it then grew 4.55% in 2025.
- A 4-year view of Convertible Debt shows it stood at $1.7 million in 2023, then grew by 28.35% to $2.2 million in 2024, then rose by 4.55% to $2.3 million in 2025, then increased by 8.7% to $2.5 million in 2026.
- The last three Convertible Debt figures came in at $2.5 million (Q1 2026), $2.3 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profusa | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 601,239.00 |
| Jun 30, 2023 | 310,999.00 |